GOLDMAN SACHS GROUP INC - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 516 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2023. The put-call ratio across all filers is 1.68 and the average weighting 1.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$133,999,157
-33.7%
1,158,261
-41.0%
0.03%
-32.5%
Q2 2023$201,988,812
+274.0%
1,963,917
+296.8%
0.04%
+263.6%
Q1 2023$54,013,932
-43.4%
494,905
-41.0%
0.01%
-47.6%
Q4 2022$95,400,133
-1.1%
838,314
-46.2%
0.02%
-4.5%
Q3 2022$96,500,000
-23.0%
1,559,201
-0.7%
0.02%
-21.4%
Q2 2022$125,281,000
-22.3%
1,570,717
+2.6%
0.03%
-17.6%
Q1 2022$161,135,000
+102.0%
1,531,545
+106.9%
0.03%
+112.5%
Q4 2021$79,778,000
+8.8%
740,328
+10.6%
0.02%
+6.7%
Q3 2021$73,293,000
+15.8%
669,100
-1.1%
0.02%
+7.1%
Q2 2021$63,320,000
-47.1%
676,206
-48.0%
0.01%
-53.3%
Q1 2021$119,684,000
+68.8%
1,300,347
+34.2%
0.03%
+66.7%
Q4 2020$70,882,000
-7.5%
968,996
-1.7%
0.02%
-14.3%
Q3 2020$76,592,000
-31.4%
985,994
-50.9%
0.02%
-38.2%
Q2 2020$111,583,000
+240.3%
2,007,625
+81.3%
0.03%
+183.3%
Q1 2020$32,791,000
+83.4%
1,107,081
+124.1%
0.01%
+140.0%
Q4 2019$17,881,000
+3.5%
493,957
-22.1%
0.01%0.0%
Q3 2019$17,273,000
-45.1%
634,360
-51.5%
0.01%
-44.4%
Q2 2019$31,448,0001,307,0790.01%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q2 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,462,634$175,978,0007.18%
SCOPIA CAPITAL MANAGEMENT LP 4,221,585$114,954,0006.73%
JW Asset Management, LLC 270,775$7,373,0006.49%
KOPP INVESTMENT ADVISORS LLC 104,462$2,845,0005.23%
1492 Capital Management LLC 171,621$4,673,0004.56%
Avoro Capital Advisors LLC 4,000,000$108,920,0004.54%
Paulson & Co. 8,170,700$222,488,0004.46%
Rhenman & Partners Asset Management AB 1,025,000$27,911,0003.50%
Redwood Investments, LLC 1,376,066$37,470,0002.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 218,000$5,938,0002.74%
View complete list of HORIZON THERAPEUTICS PUB L shareholders